SciClone Pharmaceuticals is based in Shanghai, China. It has raised $50M in total funding. Latest round: Growth.
SciClone Pharmaceuticals is based in Shanghai, China. SciClone Pharmaceuticals has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in January 2004. The round record for SciClone Pharmaceuticals runs through 2004; nothing later has been disclosed. Investors on record include GL Capital Management GP Limited, Bank of China Group Investment Limited, CDH Investments, Ascendent Capital Partners, Boying. 5 distinct backers are named across the disclosed rounds.
Every SciClone Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026